VEGFA and breast cancer: The present study demonstrated that in patients with stage I BC, the concentrations of VEGF (121.84 pg/mL) and the reference marker (20.14 U/mL) were statistically significantly higher than in the healthy controls (80.44 pg/mL; 15.94 U/mL; p = 0.008; p = 0.045, respectively).